Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study-Reference-Cited by-同舟云学术

Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study

Published:2021-06-14 Issue:4 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Emrich Insa E.¹,Heine Gunnar H.²,Schulze P. Christian³,Rogacev Kyrill S.⁴,Fliser Danilo⁵,Wagenpfeil Stefan⁶,Böhm Michael¹,Lütjohann Dieter⁷,Weingärtner Oliver³⁸^ORCID

Affiliation:

1. Internal Medicine III – Cardiology, Angiology and Intensive Care Medicine Saarland University Medical CenterSaarland University Homburg Germany

2. AGAPLESION MARKUS KRANKENHAUS Frankfurt Germany

3. Department of Internal Medicine I – Cardiology, Angiology, Intensive Care Medicine University Hospital Jena Jena Germany

4. Internal Medicine II – Cardiology Sana Hanse‐Klinikum Wismar Wismar Germany

5. Internal Medicine IV – Nephrology and Hypertension Saarland University Medical Center Homburg Germany

6. Institute for Medical Biometry, Epidemiology and Medical Informatics Saarland UniversityUniversity Medical Center Homburg Germany

7. Institute for Clinical Chemistry and Clinical Pharmacology Medical Faculty University of Bonn Bonn Germany

8. School of Medicine and Health Sciences Carl von Ossietzky UniversityUniversity Clinic of Internal Medicine, Cardiology Oldenburg Germany

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.801

Reference32 articles.

1. Cardiovascular Risk Prediction in CKD

2. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

3. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

4. Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

5. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk;Biomedicines;2023-10-26

2. Association of Kidney Function with Serum Levels of Cholesterol Absorption and Synthesis Markers: The CACHE Study CKD Analysis;Journal of Atherosclerosis and Thrombosis;2022-12-01

3. Phytosterols, Cholesterol Control, and Cardiovascular Disease;Nutrients;2021-08-16